ImmunoVec Emerges from Stealth with Significant Funding for Innovative Autoimmune Disease Therapy ImmunoVec has launched its groundbreaking cell engineering platform, supported by a $40.7 million ARPA-H award, aimed at transforming treatments for autoimmune diseases.

ImmunoVec Emerges from Stealth with Significant Funding for Innovative Autoimmune Disease Therapy #USA #Los_Angeles #ARPA-H #Autoimmune_Diseases #ImmunoVec